Welcome to our dedicated page for Genpact SEC filings (Ticker: G), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Genpact Limited filings document the disclosures of a Bermuda-based operating company listed on the NYSE and focused on agentic and advanced technology solutions. Its 8-K reports furnish quarterly and annual results, include non-GAAP reconciliations, and describe operating categories such as Advanced Technology Solutions and Core Business Services.
Genpact's proxy and annual meeting filings cover board elections, executive compensation votes, auditor matters and shareholder voting results. Other filings document material agreements and capital structure, including senior unsecured notes issued by indirect wholly owned subsidiaries and guaranteed within the Genpact group, as well as officer appointments and related governance disclosures.
Genpact Limited reported a routine compensation-related share withholding for its Senior Vice President and CHRO, Piyush Mehta. On March 10, 5,702 common shares were withheld at $38.92 per share to cover taxes upon vesting of performance share units granted on March 15, 2023. Following this tax-withholding disposition, Mehta directly holds 156,485 common shares, reflecting his ongoing equity stake in the company rather than an open-market sale.
Genpact Limited Senior Vice President Sameer Dewan reported a tax-related share disposition tied to equity compensation. On this Form 4, 3,542 common shares were withheld at a value of $38.92 per share to cover taxes upon vesting of performance share units granted on March 15, 2023.
After this withholding, Dewan directly holds 57,665 common shares. This transaction reflects routine tax withholding on vested performance-based awards under the Genpact Limited 2017 Omnibus Incentive Compensation Plan rather than an open-market purchase or sale decision.
Genpact Limited President and CEO Balkrishan Kalra reported a tax-related share withholding. On the vesting of performance share units granted on March 15, 2023, 13,893 common shares were withheld to cover tax obligations, rather than sold in the market. Following this non-market disposition, he continues to hold 511,114 common shares directly.
Genpact Limited is soliciting proxies for its 2026 Annual General Meeting on April 23, 2026 in New York. Shareholders are being asked to elect ten directors, approve executive pay on an advisory basis, and ratify KPMG as independent auditor for 2026.
For 2025, Genpact reported net revenues of $5.08 billion, up 6.6% year-over-year, with Advanced Technology Solutions reaching $1.20 billion, up 17.0% and now 24% of total revenue. Adjusted diluted EPS grew 11%, marking a fifth straight year of EPS growth outpacing revenue. The company highlights a strategy centered on AI- and agentic-based solutions, strong partner-driven revenue growth, and extensive governance practices including an independent chair, fully independent key committees, annual director elections, and robust shareholder engagement on compensation.
Genpact Ltd President and CEO Balkrishan Kalra reported multiple equity transactions. On March 4, 2026, he exercised an employee stock option for 2,800 common shares at $27.65 per share, then sold 2,800 common shares in an open‑market transaction at a weighted average price of $40.77, leaving 525,007 common shares held directly afterward.
On March 3, 2026, he also acquired 27,160 common shares as a grant or award at no cost, increasing his direct holdings. Footnotes note performance share units granted on March 15, 2023 that will vest on March 10, 2026, and 8,962 shares currently held under the employee stock purchase plan, including 587 shares bought since his prior Form 4.
Genpact LTD reported that Senior Vice President Sameer Dewan acquired 6,928 common shares through a grant/award transaction at a price of $0.00 per share. Following this award, he directly holds 61,207 common shares.
These shares relate to performance share units granted on March 15, 2023, for which the performance conditions have been satisfied. Each unit represents the right to receive one common share, and the units will vest on March 10, 2026, subject to his continued service.
Genpact LTD Senior Vice President and CHRO Piyush Mehta reported an equity award of 14,618 common shares. The shares relate to performance share units granted on March 15, 2023, for which performance conditions have been satisfied. These PSUs will vest on March 10, 2026, if he continues in service through that date.
Following this grant, Mehta directly holds 162,187 common shares, including 10,512 shares under Genpact’s Employee Stock Purchase Plan, of which 153 were acquired since his prior Form 4 filed on February 3, 2026.
Nanduru Anil reported acquisition or exercise transactions in this Form 4 filing.
Genpact LTD Senior Vice President Nanduru Anil reported an equity award of 13,856 common shares. These shares relate to performance share units granted on March 15, 2023, for which the performance conditions have been satisfied.
Each PSU represents the right to receive one common share. The units are scheduled to vest on March 10, 2026, subject to the executive’s continued service through that date. Following this award, Anil’s directly held stake is reported as 113,202 common shares.
Genpact LTD reported that Senior Vice President Riju Vashisht acquired 13,856 common shares at no cost through the settlement of performance share units granted on March 15, 2023. The transaction increased her directly held stake to 130,748 common shares.
The underlying performance share units will vest on March 10, 2026, subject to her continued service, with each unit representing the right to receive one common share.